This section contains links to useful resources from the College concerning PET-CT, as well as links to relevant pages within the ARSAC website.
The radiologist and nuclear medicine, 2nd edn (2012 - currently under review): This paper addresses the specific issues related to radiologists working in a nuclear medicine environment.
Recent and future PET-CT developments: guidance on legislative and training aspects for members and Fellows (2013): A guidance document from the RCR designed to update members and Fellows on recent and future developments related to PET-CT and how this may impact on established imaging specialists who have limited or no training in the technique.
Evidence-based indications for the use of PET-CT in the UK 2016 (2016): Since its introduction to clinical practice, positron emission tomography-computed tomography (PET-CT) has become a key investigative tool in the assessment of cancer and non-cancer medical conditions. This guidance comprises a summary of relevant indications for the use of positron emission tomography – computed tomography (PET-CT), where there is good evidence that patients will benefit from improved disease assessment resulting in altered management and improved outcomes. The indications are divided into oncological and non-oncological applications then body area/system. Now in its third edition, the 2016 version of these guidelines builds on the evidence cited in earlier editions.
Guidelines for the use of PET-CT in children, Second edition (2014): In the face of limited published data and experience, this report was compiled by individuals with experience in scanning children with PET-CT in the UK and paediatricians involved in clinical management of the type of conditions for which PET-CT is likely to be used. It represents a consensus reached between the authors of what is desirable ‘best’ practice.
Body PET CT and CT Brain Scanning in diagnostic staging of Non Small Cell Lung Cancer (NSCLC) (2010, updated 2015): An audit on patients with NSCLC who are potential candidates for radical treatment with either Surgery or Radiotherapy should have body PET CT and contrast enhanced CT brain scan prior to referral.
Administration of Radioactive Substances Advisory Committee (ARSAC)
ARSAC advises government on the certification of doctors and dentists who want to use radioactive medicinal products on people.
- About ARSAC
- ARSAC Notes for Guidance on the Clinical Administration of Radiopharmaceuticals and Use of Sealed Radioactive Sources
- ARSAC application forms
- How and when to submit research applications to ARSAC